AAAAAA

   
Results: 1-17 |
Results: 17
POLYCYTHEMIA-VERA TREATED WITH PIPOBROMAN AS SINGLE-AGENT - LOW INCIDENCE OF SECONDARY LEUKEMIA IN A COHORT OF PATIENTS OBSERVED DURING 20 YEARS (1971-1991)
Authors: PETTI MC SPADEA A AVVISATI G SPADEA T LATAGLIATA R MONTEFUSCO E COSENZA M MALAGNINO F
Citation: Mc. Petti et al., POLYCYTHEMIA-VERA TREATED WITH PIPOBROMAN AS SINGLE-AGENT - LOW INCIDENCE OF SECONDARY LEUKEMIA IN A COHORT OF PATIENTS OBSERVED DURING 20 YEARS (1971-1991), Leukemia, 12(6), 1998, pp. 869-874
ANAGRELIDE IN ESSENTIAL THROMBOCYTHEMIA (ET)
Authors: PERAINO M BIZZONI L BERNASCONI S SPADEA A RUSSO D CERVELLERA M MAZZUCCONI MG
Citation: M. Peraino et al., ANAGRELIDE IN ESSENTIAL THROMBOCYTHEMIA (ET), Thrombosis research, 91(3), 1998, pp. 46-46
SALVAGE LUNG RESECTION FOR MASSIVE HEMOPTYSIS AFTER RESOLUTION OF PULMONARY ASPERGILLOSIS IN A PATIENT WITH ACUTE-LEUKEMIA
Authors: VENUTA F RENDINA EA PESCARMONA E FRANCIONI F FAZI P SPADEA A RICCI C
Citation: F. Venuta et al., SALVAGE LUNG RESECTION FOR MASSIVE HEMOPTYSIS AFTER RESOLUTION OF PULMONARY ASPERGILLOSIS IN A PATIENT WITH ACUTE-LEUKEMIA, SC CARDIOVA, 31(1), 1997, pp. 51-53
THE ROLE OF ALL-TRANS-RETINOIC ACID (ATRA) TREATMENT IN NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA PATIENTS AGED GREATER-THAN-60 YEARS
Authors: LATAGLIATA R AVVISATI G LOCOCO F PETTI MC DIVERIO D SPADEA A FAZI P TORROMEO C BRECCIA M MALAGNINO F MANDELLI F
Citation: R. Latagliata et al., THE ROLE OF ALL-TRANS-RETINOIC ACID (ATRA) TREATMENT IN NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA PATIENTS AGED GREATER-THAN-60 YEARS, Annals of oncology, 8(12), 1997, pp. 1273-1275
CYTOREDUCTIVE THERAPY OF ESSENTIAL THROMBOCYTHEMIA - PROPOSAL OF A SCORE SYSTEM
Authors: SPADEA A PERAINO M BERNASCONI S LATAGLIATA R PETTI MC MAZZUCCONI MG
Citation: A. Spadea et al., CYTOREDUCTIVE THERAPY OF ESSENTIAL THROMBOCYTHEMIA - PROPOSAL OF A SCORE SYSTEM, Thrombosis and haemostasis, 1997, pp. 181-181
LOW-DOSE ASPIRIN IN POLYCYTHEMIA-VERA - A PILOT-STUDY
Authors: BARBUI T DEGAETANO G FINAZZI G LANDOLFI R MARCHIOLI R PATRONO C TOGNONI G CAPANI F DECARLI A GAMBI D NENCI GG TURA S MANDELLI F ROSSIFERRINI P CORTELAZZO S VESTRI O FINELLI C NOCENTINI F POGLIANI EM MICCOLIS IR BIZZI B ROCCA B TARTAGILIONE R ANGELI G DIBLASIO A DIPASQUALE A KRAMER V MARFISI RM OLIVIERI M SCIULLI L SPOLTORE R MONTEFUSCO E SPADEA A CAROTENUTO M NOBILE M MORELLI A RESEGOTTI L VASINO MAC RODEGHIERO F RUGGERI M
Citation: T. Barbui et al., LOW-DOSE ASPIRIN IN POLYCYTHEMIA-VERA - A PILOT-STUDY, British Journal of Haematology, 97(2), 1997, pp. 453-456
TREATMENT OF HIGH-RISK MYELODYSPLASTIC SYNDROMES WITH LYMPHOBLASTOID ALPHAS INTERFERON
Authors: PETTI MC LATAGLIATA R AVVISATI G SPIRITI MAA MONTEFUSCO E SPADEA A MANDELLI F
Citation: Mc. Petti et al., TREATMENT OF HIGH-RISK MYELODYSPLASTIC SYNDROMES WITH LYMPHOBLASTOID ALPHAS INTERFERON, British Journal of Haematology, 95(2), 1996, pp. 364-367
THE ROLE OF ALL-TRANS-RETINOIC ACID (ATRA) TREATMENT IN NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA (APL) PATIENTS AGED GREATER-THAN 60 YRS
Authors: LATAGLIATA R PETTI MC DIVERIO D FAZI P MECAROCCI S MONTEFUSCO E REDI R SPADEA A TORROMEO MC AVVISATI G
Citation: R. Latagliata et al., THE ROLE OF ALL-TRANS-RETINOIC ACID (ATRA) TREATMENT IN NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA (APL) PATIENTS AGED GREATER-THAN 60 YRS, Blood, 88(10), 1996, pp. 3425-3425
MEC (MITOXANTRONE, ETOPOSIDE AND INTERMEDIATE-DOSE CYTARABINE) - AN EFFECTIVE INDUCTION REGIMEN FOR PREVIOUSLY UNTREATED ACUTE NONLYMPHOCYTIC LEUKEMIA
Authors: VISANI G PETTI MC CENACCHI A MANFROI S TOSI P SPADEA A LATAGLIATA R AMADORI S MANDELLI F TURA S
Citation: G. Visani et al., MEC (MITOXANTRONE, ETOPOSIDE AND INTERMEDIATE-DOSE CYTARABINE) - AN EFFECTIVE INDUCTION REGIMEN FOR PREVIOUSLY UNTREATED ACUTE NONLYMPHOCYTIC LEUKEMIA, Leukemia & lymphoma, 19(5-6), 1995, pp. 447-451
IS AGGRESSIVE CHEMOTHERAPY THE BEST CHOICE FOR PATIENTS WITH ACUTE NONLYMPHOCYTIC LEUKEMIA AFTER MYELODYSPLASTIC SYNDROMES
Authors: LATAGLIATA R SPIRITI MAA AVVISATI G DEGREGORIS C FAZI P SPADEA A PETTI MC
Citation: R. Latagliata et al., IS AGGRESSIVE CHEMOTHERAPY THE BEST CHOICE FOR PATIENTS WITH ACUTE NONLYMPHOCYTIC LEUKEMIA AFTER MYELODYSPLASTIC SYNDROMES, Leukemia research, 19(3), 1995, pp. 213-217
THE RETINOBLASTOMA GENE-PRODUCT IN ACUTE MYELOID-LEUKEMIA - A POSSIBLE INVOLVEMENT IN PROMYELOCYTIC LEUKEMIA
Authors: PAGGI MG DEFABRITIIS P BONETTO F AMADIO L SANTARELLI G SPADEA A GENTILE FP FLORIDI A FELSANI A
Citation: Mg. Paggi et al., THE RETINOBLASTOMA GENE-PRODUCT IN ACUTE MYELOID-LEUKEMIA - A POSSIBLE INVOLVEMENT IN PROMYELOCYTIC LEUKEMIA, Cancer research, 55(20), 1995, pp. 4552-4556
POLYCYTHEMIA-VERA - THE NATURAL-HISTORY OF 1213 PATIENTS FOLLOWED FOR20 YEARS
Authors: RIUNITI O BARBUI T FINAZZI G NEGRI M SUD CMN DEGAETANO G MARCHIOLI R TOGNONI G PATRONO C LANDOLFI R DITORRETTE ON LEONI P RUPOLI S CORTELAZZO S VESTRI O TURA S FINELLI C NOCENTINI F ANGELI G DIPASQUALE A KRAMER V MARFISI R OLIVIERI M SCIULLI L SPOLTORE R CAREGGI P FERRINI PR GROSSI A LONGO G NIGUARDA O DECATALDO F GARGANTINI L BAUDO F GERARDO S POGLIANI EM MICCOLIS IR BIZZI B ROCCA B TARTAGLIONE R MANDELLI F MONTEFUSCO E SPADEA A GIOVANNI S CAROTENUTO M NOBILE M MORELLI R MOLINETTE O RESEGOTTI L VASINO MAC BARTOLO OS RODEGHIERO F RUGGERI M ROSSIFERRINI P
Citation: O. Riuniti et al., POLYCYTHEMIA-VERA - THE NATURAL-HISTORY OF 1213 PATIENTS FOLLOWED FOR20 YEARS, Annals of internal medicine, 123(9), 1995, pp. 656
POOR-RISK AML WITH HIGH RHODAMINE-123 EFFLUX VALUE UNDERGOING FLAG REGIMEN - EVALUATION OF PROLIFERATIVE CHANGES INDUCED BY G-CSF
Authors: TAFURI A DEFELICE L PETRUCCI MT MASCOLO MG VALENTINI T SPADEA A MANDELLI F PETTI MC
Citation: A. Tafuri et al., POOR-RISK AML WITH HIGH RHODAMINE-123 EFFLUX VALUE UNDERGOING FLAG REGIMEN - EVALUATION OF PROLIFERATIVE CHANGES INDUCED BY G-CSF, Blood, 84(10), 1994, pp. 10000046-10000046
PIPOBROMAN IN POLYCYTHEMIA-VERA PATIENTS - A RETROSPECTIVE ANALYSIS
Authors: SPADEA A PETTI MC SPIRITI MAA AVVISATI G LATAGLIATA R MONTEFUSCO E MANDELLI F
Citation: A. Spadea et al., PIPOBROMAN IN POLYCYTHEMIA-VERA PATIENTS - A RETROSPECTIVE ANALYSIS, Blood, 84(10), 1994, pp. 10000058-10000058
MITOXANTRONE, ETOPOSIDE AND INTERMEDIATE-DOSE ARA-C (MEC) - AN EFFECTIVE REGIMEN FOR POOR RISK ACUTE MYELOID-LEUKEMIA
Authors: SPADEA A PETTI MC FAZI P VEGNA ML ARCESE W AVVISATI G SPIRITI MAA LATAGLIATA R MELONI G TESTI AM AMADORI S MANDELLI F
Citation: A. Spadea et al., MITOXANTRONE, ETOPOSIDE AND INTERMEDIATE-DOSE ARA-C (MEC) - AN EFFECTIVE REGIMEN FOR POOR RISK ACUTE MYELOID-LEUKEMIA, Leukemia, 7(4), 1993, pp. 549-552
ERYTHROPOIETIN TREATMENT OF IDIOPATHIC MYELOFIBROSIS
Authors: SPIRITI MAA LATAGLIATA R AVVISATI G BATTISTEL V MONTEFUSCO E SPADEA A PETTI MC
Citation: Maa. Spiriti et al., ERYTHROPOIETIN TREATMENT OF IDIOPATHIC MYELOFIBROSIS, Haematologica, 78(6), 1993, pp. 371-373
RECOMBINANT-HUMAN-ERYTHROPOIETIN IN THE TREATMENT OF MYELODYSPLASTIC SYNDROMES - AN INTERIM-REPORT
Authors: SPIRITI MAA PETTI MC LATAGLIATA R AVVISATI G DEGREGORIS C PROIA S FAZI P JAALOUK G MANCINI M SPADEA A VILLA R MANDELLI F
Citation: Maa. Spiriti et al., RECOMBINANT-HUMAN-ERYTHROPOIETIN IN THE TREATMENT OF MYELODYSPLASTIC SYNDROMES - AN INTERIM-REPORT, Haematologica, 78(2), 1993, pp. 123-126
Risultati: 1-17 |